A two-chain insulin analogue uses a diol side chain and glucose-binding element to trigger conformational switching.
Segmenting synthesis into modular stages resolves yield-purity trade-offs by preventing epimerization during controlled lactamization.
Segmented synthesis of etelcalcetide intermediate using Mmt protecting group prevents side reactions, raising crude purity to 90.3% and total yield to 65%.
Sequential ion exchange and adsorption chromatography purify low isoelectric point erythropoietin analogs, reducing complexity and cost.
Segments synthesis into protected amino acid mixtures to resolve batch-to-batch reproducibility issues in peptide combination manufacturing.
Specific amino acid substitutions in the Fc-binding protein improve acid stability, resolving industrial storage limitations for antibody adsorbents.
Mixed-phase solid phase extraction material removes salts, lipids, and interfering ions from biological samples to achieve high purity levels.
Base-triggered on-resin cyclization overcomes acid sensitivity in N-methyl amino acids, improving synthesis efficiency and chemical diversity.
Cold homogenization preserves protein structural integrity while extracting pharmaceutical grade heparin from mammalian intestine mucosa.
Biotinylated trypsin digestion allows efficient removal of autolysis contaminants through affinity chromatography, ensuring high purity proteomic samples.
Binding reducing agents to a solid support converts trisulfide bonds to disulfide bonds, preventing protein aggregation caused by free reagents.
High-concentration ethanol washing minimizes water content to reduce protein loss below 25%.
Segmented purification using acid treatment and selective binding overcomes HPLC scalability limits.